|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:PerkinElmer
Acquired_by_PerkinElmer
|
|
gptkbp:awards
|
Innovative Technology Award 2020
Top 100 Private Companies 2021
Best_Biotechnology_Company_2019
|
|
gptkbp:CEO
|
Terry_Pizzie
|
|
gptkbp:competitors
|
gptkb:Agilent_Technologies
gptkb:Editas_Medicine
gptkb:Intellia_Therapeutics
gptkb:Thermo_Fisher_Scientific
gptkb:Sangamo_Therapeutics
gptkb:CRISPR_Therapeutics
Illumina
Cellectis.
|
|
gptkbp:employees
|
200+
|
|
gptkbp:founded
|
2007
|
|
gptkbp:founder
|
gptkb:Darrin_Disley
|
|
gptkbp:hasClient
|
Government Agencies
Academic Institutions
Pharmaceutical Companies
Research Organizations
Biotech_Companies
|
|
gptkbp:hasEmployees
|
200-500
|
|
gptkbp:hasFunding
|
Public Offering
Venture_Capital
|
|
gptkbp:hasLocation
|
gptkb:Asia
gptkb:North_America
Europe
|
|
gptkbp:hasPartnershipsWith
|
gptkb:Harvard_University
gptkb:Johns_Hopkins_University
gptkb:Stanford_University
gptkb:University_of_Cambridge
gptkb:MIT
|
|
gptkbp:hasProductLine
|
gptkb:Horizon_Knockout_Cell_Lines
gptkb:Horizon_Genome_Editing
Horizon CRISPR Libraries
Horizon RNAi Libraries
Horizon_Cell_Models
|
|
gptkbp:hasResidence
|
$50 million - $100 million
|
|
gptkbp:hasService
|
Screening Services
Gene_Editing_Services
Assay_Development_Services
Cell_Characterization_Services
Custom_Cell_Line_Development
|
|
gptkbp:hasTechnology
|
Gene Editing Technology
CRISPR/Cas9
RNA Interference
Gene_Synthesis
Cell_Line_Engineering
|
|
gptkbp:headquarters
|
gptkb:Cambridge,_Massachusetts
gptkb:Cambridge,_UK
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Horizon Discovery (US) Inc.
|
|
gptkbp:industry
|
Biotechnology
|
|
gptkbp:investmentFocus
|
Various venture capital firms
|
|
gptkbp:keyPeople
|
gptkb:David_A._H._Smith
gptkb:Katherine_Stowe
gptkb:Darrin_Disley
gptkb:Mark_H._Hargreaves
Robert_A._H._Hargreaves
|
|
gptkbp:location
|
gptkb:United_States
|
|
gptkbp:market
|
Global
|
|
gptkbp:offers
|
CRISPR technology
Cell line development
Gene modulation
|
|
gptkbp:operatesIn
|
gptkb:United_States
Europe
|
|
gptkbp:parentCompany
|
gptkb:Horizon_Discovery_Group_plc
|
|
gptkbp:partnerships
|
Various pharmaceutical companies
|
|
gptkbp:products
|
Gene_editing_tools
|
|
gptkbp:researchFocus
|
Genetic research
|
|
gptkbp:revenue
|
$50 million (2020)
|
|
gptkbp:services
|
Cell line development
|
|
gptkbp:specialization
|
Gene modulation
|
|
gptkbp:specializesIn
|
Gene_editing
|
|
gptkbp:subsidiary
|
gptkb:Horizon_Discovery_Ltd.
gptkb:Horizon_Discovery_(UK)_Ltd.
Horizon_Discovery_(Asia)_Pte._Ltd.
Horizon_Discovery_(Europe)_GmbH.
|
|
gptkbp:technology
|
CRISPR
Gene synthesis
RNAi
Cell line engineering
|
|
gptkbp:website
|
www.horizondiscovery.com
|